Skip to main content

Animations

The Parkinson's Precision Medicine Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.


  • Scientist in Lab

    The Appendix and Parkinson's: 'It's a Piece to the Puzzle'

    Rachel Dolhun, MD, vice president of medical communication at the Foundation comments on these findings.
    Learn more Save for later

  • Default content image

    Parkinson's Research: PPMI Clinical Study

    Learn more Save for later

  • Default content image

    Parkinson's Progression Markers Initiative

    Learn more Save for later

  • PPMI: The Benefits of Collaboration & Digital Health

    PPMI: The Benefits of Collaboration & Digital Health

    Deputy CEO, Sohini Chowdhury, talked to Roche for an article discussing PPMI and the importance of sharing data.
    Learn more Save for later

  • Tests for Parkinson's within Reach

    Tests for Parkinson's within Reach

    Parkinson's scientists say tests to predict the course of the disease are within reach thanks to investment in large-scale studies and standardized methods.
    Learn more Save for later

  • Summit Outlines Needs to Advance Parkinson's Cures

    Summit Outlines Needs to Advance Parkinson's Cures

    The Michael J. Fox Foundation gathered leaders from industry, academia, non-profits and government to discuss the way forward in Parkinson's drug trials.
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.